Clinical Trial Update: Gene Therapy for WAS [Phase 1, Phase 2]

View source ↗

Summary

Genethon's Phase 1/2 gene therapy trial for Wiskott-Aldrich Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wiskott-aldrich Syndrome

Drugs mentioned

• WAS Gene Therapy

Snippet

Sponsor: Genethon | Conditions: Wiskott-Aldrich Syndrome | Phase 1, Phase 2 | Status: COMPLETED